## CI: The Cigna Group - XLV: Healthcare

### Executive Summary

No clear thesis: MRS_10 at 3.9%, does not meet entry criteria. Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($263.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. CI STOCK ALERT: Levi & Korsinsky Notifies The Cigna Group Investors of an Ongoing Investigation**
- Source: ACCESS Newswire | 20251215T140756 | Bearish | Relevance: 100%
- Levi & Korsinsky has launched an investigation into The Cigna Group (NYSE:CI) for potential federal securities law violations. This investigation follows CI's third-quarter 2025 earnings report, which revealed an increase in their Healthcare MCR to 84.8% from 82.8% in 2024, attributed to their Individual and Family Plans business and higher stop loss medical costs. This news led to a 17% drop in CI's stock price on October 30, 2025.

**2. Rep. Julie Johnson Sells International Paper Company (NYSE:IP) Shares**
- Source: MarketBeat | 20251215T132120 | Neutral | Relevance: 75%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of International Paper Company (NYSE:IP) shares on November 3rd, 2025, from her Merrill Lynch account. The company previously missed quarterly EPS expectations but reported a 56.4% revenue growth and announced a quarterly dividend of $0.4625. International Paper currently holds a consensus "Hold" rating with a $50.44 price target from analysts.

**3. Rep. Julie Johnson Sells RTX Corporation (NYSE:RTX) Shares**
- Source: MarketBeat | 20251215T101053 | Somewhat-Bearish | Relevance: 74%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 of RTX Corporation (NYSE: RTX) stock on November 13th. She also made similar-sized sales in several other large-cap stocks on the same day. RTX recently beat quarterly earnings estimates, has a "Moderate Buy" consensus rating from analysts, and paid a quarterly dividend.

**4. Rep. Julie Johnson Sells Off Shares of PepsiCo, Inc. (NASDAQ:PEP)**
- Source: MarketBeat | 20251215T102448 | Somewhat-Bearish | Relevance: 73%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of PepsiCo (NASDAQ:PEP) stock, along with similar amounts of other major company stocks, on November 13, 2025. PepsiCo is trading near $150.65, with analysts maintaining a "Hold" rating and a target price of $158.35. The company recently declared a quarterly dividend of $1.4225, representing a 3.8% yield.

**5. Rep. Julie Johnson Sells Off Shares of Walmart Inc. (NASDAQ:WMT)**
- Source: MarketBeat | 20251215T101106 | Neutral | Relevance: 73%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of Walmart stock on November 13th, as disclosed in a December 11th filing. This sale was part of several recent transactions where Rep. Johnson also divested shares in other major companies including Charles Schwab, UnitedHealth Group, and Capital One Financial. The article details Walmart's recent stock performance, earnings, analyst ratings, and other insider trading activities.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($1.01M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.1%)
- Blackrock Inc.: 8.3% (-1.1%)
- JPMORGAN CHASE & CO: 5.0% (+106.4%)
- State Street Corpora: 4.5% (-1.2%)
- Price (T.Rowe) Assoc: 4.2% (+9.8%)

### Key Risks

1. Long-term trend broken: trading 8.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +7.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 9.0x stretched relative to 3% growth. Balance sheet: $3.1B free cash flow. Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.8B |
| Beta | 0.26 |
| 52W Range | $239.51 - $350.00 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 9.0 |
| Current P/E | 9.3 |
| YoY Growth | 3.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.1% to 3.9% (+7.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 87th percentile. MRS_5 at 2.2% confirms short-term momentum alignment. Outperforming sector by 3.9pp, stock-specific strength. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (1.34), confirming momentum. RSI neutral at 53. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.91% (CS: 88) | Strong |
| RSI_14 | 53.2 | Neutral |
| MACD Histogram | 1.34 | Bullish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 0.913x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $275.98
- **Stop Loss:** $263.04 (4.7% risk)
- **Target:** $288.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $21,250.46
- **Portfolio %:** 21.25%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-05 (Est: $7.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.64 | $7.83 | +2.5% |
| 2025Q2 | $7.15 | $7.20 | +0.6% |
| 2025Q1 | $6.35 | $6.74 | +6.2% |
| 2024Q4 | $7.82 | $6.64 | -15.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*